- Roche - Doing now what patients need next
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally
- Roche Pharmaceuticals
Roche Pharmaceuticals is focused on translating excellence in science into effective medicines for patients It combines cutting-edge research at Roche, Genentech, in the US Chugai in Japan and over 250 partners worldwide with global scale and reach in clinical development, manufacturing and commercial operations Thanks to the Pharma Division's broad-based portfolio, Roche is one of the world
- About Roche
About Roche Since our founding over 125 years ago, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day
- Roche Diagnostics
Roche introduces vertical and overhead transportation, enabling crossing walkways, floor to floor transportation, splitting the solution across different work areas and much more
- Focus Areas - Roche
Finding innovative solutions for unmet medical needs is at the heart of what we do Our ideas and research help save lives
- Roche | Locations
Roche Pharmaceuticals A S Roche Pharmaceuticals A S Flaskehalsen 17 1799 Copenhagen 4 sal Denmark View on google maps +45 3639 9999
- Roche Diagnostics
Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases
- Roche to invest USD 50 billion in pharmaceuticals and diagnostics in . . .
Basel, 22 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will invest USD 50 billion into the United States of America in the next five years These investments further strengthen Roche’s already significant US footprint with 13 manufacturing and 15 R D sites across the Pharmaceutical and Diagnostics Divisions, and are expected to create more than 12,000 new jobs
|